Business · Companies · 5 hrs ago
Merz Aesthetics executive says cosmetic medicine is no longer niche
Gonzalo Mibelli, Merz Aesthetics' EMEA president, says aesthetic medicine is moving beyond a niche market and becoming part of a wider beauty, wellness and longevity industry.
The global market for manufacturing aesthetic medicine products was worth about $25 billion in 2025, with annual growth estimated at 6% through 2030.
Consumers are increasingly seeking natural, personalised results and treatments that change gradually without altering their identity.
Mibelli says artificial intelligence is changing how people learn about procedures; a Boston Consulting Group study found 75% of US beauty product consumers use AI for information.
AI may help patients prepare for consultations, but clinicians must address false information, unrealistic expectations and privacy, while retaining medical judgment.
Younger people are taking up preventive treatments earlier, and Mibelli says prevention should begin with a medical assessment and a conservative plan when clinically appropriate.
He says evidence, product quality and professional training matter as the market grows, though the interview gives no specific next steps.
Gonzalo Mibelli, Merz Aesthetics’ president for Europe, the Middle East and Africa, says aesthetic medicine has moved beyond a niche market.
He describes the market as resilient and increasingly part of a wider beauty, wellbeing and longevity ecosystem.
Global manufacturing of aesthetic medicine products was valued at about $25 billion in 2025, with annual growth estimated at 6% through 2030.
Mibelli says consumers are seeking natural-looking, personalised results and showing greater interest in preventive treatments.
He says artificial intelligence can help consumers prepare for clinical consultations but also raises concerns about misinformation, expectations and personal data.
- Who
- Gonzalo Mibelli, president of Merz Aesthetics for Europe, the Middle East and Africa.
- What
- He says aesthetic medicine is no longer a niche market and discusses industry trends, artificial intelligence and preventive treatments.
- When
- The interview was published on November 4, 2026.
- Where
- The interview concerns the global aesthetic medicine market. Mibelli lives in Frankfurt.
- Why
- Mibelli says the market is growing and becoming part of a broader beauty, wellbeing and longevity ecosystem.
This story does not have two clearly opposing sides.
The global manufacturing market for aesthetic medicine products reached an approximate value of $25 billion.
Annual growth in the global market is estimated at 6%.
Expansión published its interview with Gonzalo Mibelli.
- Company
- Merz Aesthetics
- Executive
- Gonzalo Mibelli, president for Europe, the Middle East and Africa
- Market value
- About $25 billion in 2025
- Estimated growth
- 6% annually through 2030
- AI use
- 75% of US beauty-product consumers use AI for information, according to a Boston Consulting Group study
What people are saying
The aesthetic medicine market continues to show great opportunities and resilience, moving from a niche category to form part of a broader ecosystem of beauty, wellbeing and longevity.
The market is increasingly oriented towards natural, personalised and hard-to-detect results.
This can lead to a better-informed patient and a more enriching conversation with the doctor, but it also raises the need to correct misinformation, manage unrealistic expectations, protect personal data and keep clinical judgement in the hands of the healthcare professional.
Prevention should consist of an assessment by a medical professional to draw up a conservative long-term plan, rather than an immediately excessive treatment, and should be accompanied by healthy lifestyle habits.